Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Uterine sarcoma
Keywords/Phrases:  leiomyosarcoma
Trial Status:  Active
Sponsor of Trial:  NCI
Results 1-5 of 5 for your search:
Start Over
Nivolumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-02403, 9672, P30CA006516, UM1CA186709, NCT02428192
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0277, NCI-2012-00249, CDR0000724874, IRCI 001, U10CA027469, NCT01533207
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13-03-096, NCI-2013-01364, 13-014, P30CA013330, NCT01958580
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Phase: No phase specified
Type: Genetics, Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: 890086, 89-C-0086, NCT00001238
Collecting Tumor Samples From Patients With Gynecological Tumors
Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000078647, GOG-0136, NCT00897442
Start Over